00:00It's Benzinga, bringing Wall Street to Main Street.
00:02Eli Lilly shares fell 3.17% Wednesday, pulling back after reaching an all-time high last week,
00:09according to Benzinga. The stock hit an intraday record of $1,292.65 on August 19th,
00:18before easing in recent sessions. Separately, Eli Lilly reported real-world data showing older
00:24adults who continued taking ZepBound had lower health care costs than untreated patients.
00:30Monthly costs were up to 15% lower after six months, representing about $181 in savings per patient.
00:39After one year, savings reached about $607 per month, or 38%. Patients taking ZepBound also had
00:46fewer hospital and emergency room visits. Shares were down by 0.01% at $1,189.30 in Thursday's
00:56pre-market trading, according to data from Benzinga Pro. For all things money, visit Benzinga.com.
Comments